Dear Business & Industry Insider,
With this edition of the Business & Industry Insider, we bring you the story of the rise, fall, and rise again of Merge Healthcare.
The Milwaukee radiology informatics company became something of a punching bag in the medical imaging industry after an accounting scandal in 2006 led to two years of shareholder lawsuits, delisting notifications, and layoffs.
Merge's decline eventually led to an investment firm taking a major stake in the company and installing its own management team. One year later, Merge appears to have put the bad times behind it with four straight profitable quarters.
Will the recovery stick? Decide for yourself by reading this edition's Insider Exclusive, which you can reach by clicking here.
In other news in your Business & Industry Digital Community, learn about the latest in patent litigation over contrast injection technology between Bracco Imaging of Milan, Italy, and the Mallinckrodt division of Covidien of Dublin, Ireland. The firms are dueling over MRI contrast devices ... find out the latest developments in the case by clicking here.
Finally, Canadian nuclear reactor operator Atomic Energy of Canada (AECL) this week confirmed that it is committed to restarting the National Research Universal reactor, which has been at the heart of a shortfall in supplies of the radioisotope molybdenum-99. The announcement should allay fears that AECL would abandon the aging facility and leave the nuclear medicine community scrambling for a long-term source of the radioisotope. Get an update by clicking here.
